Douglas C. Chang

Douglas C. Chang

Auto-generated profile, based on publicly available information

Douglas C. Chang

Phoenix Epidemiology and Clinical Research Branch National Institute of Diabetes and Digestive and Kidney Diseases Phoenix Arizona USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
DCDouglas C. Chang
Douglas C. Chang
XXXiaoyuan Xu
Xiaoyuan Xu
AFAnthony W. Ferrante
Anthony W. Ferrante
JKJonathan Krakoff
Jonathan Krakoff
Plasma albumin is reduced during inflammation. Obesity, a strong risk factor for type 2 diabetes (T2D), is associated with adipose tissue inflammation. However, whether albumin is associated with adipose tissue inflammation and whether it predicts T2D are unclear. Adults (predominantly American Indian) from a longitudinal study were included. Macrophage content and gene expression related to recruitment/activation were measured from subcutaneous adipose tissue (n = 51). The relationship between plasma albumin and adiposity (dual-energy X-ray absorptiometry or hydrodensitometry), glucose (oral glucose tolerance test), insulin action (hyperinsulinemic-euglycemic clamp), and insulin secretion (intravenous glucose tolerance test) were evaluated (n = 422). Progression to T2D was evaluated by Cox regression (median follow-up 8.8 years; 102 progressors). Albumin was associated with macrophage markers including C1QB (r = − 0.30, p = 0.04), CSF1R (r = − 0.30, p = 0.03), and CD11b (r = − 0.36, p = 0.01). Albumin was inversely associated with body fat percentage (r = − 0.14, p = 0.003), fasting plasma glucose (r = − 0.17, p = 0.0003), and 2 h plasma glucose (r = − 0.11, p = 0.03), and was reduced in impaired glucose regulation compared with normal glucose regulation (mean ± SD: 39.4 ± 3.6 g/l and 40.1 ± 3.9 g/l, respectively; p = 0.049). Albumin predicted T2D, even after adjustment for confounders (HR, 0.75; 95% CI 0.58–0.96; p = 0.02; per one SD difference in albumin). Reduced albumin is associated with an unfavorable metabolic profile, characterized by increased adipose tissue inflammation, adiposity, and glucose, and with an increased risk for T2D.

29 June 2017 in Diabetologia
Verified
Journal Article
Closed access
PDF file
EPEthan Paddock
Ethan Paddock
MHMaximilian G. Hohenadel
Maximilian G. Hohenadel
Paolo PiaggiPaolo Piaggi
Paolo Piaggi
PVPavithra Vijayakumar
Pavithra Vijayakumar
RHRobert L. Hanson
Robert L. Hanson
DCDouglas C. Chang
Douglas C. Chang

6 January 2021 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MSMujtaba Shah
Mujtaba Shah
Paolo PiaggiPaolo Piaggi
Paolo Piaggi
HLHelen C. Looker
Helen C. Looker
EPEthan Paddock
Ethan Paddock
JKJonathan Krakoff
Jonathan Krakoff
DCDouglas C. Chang
Douglas C. Chang

5 April 2018 in Diabetes Care
Verified
Journal Article
Closed access
EPEthan Paddock
Ethan Paddock
HLHelen C. Looker
Helen C. Looker
Paolo PiaggiPaolo Piaggi
Paolo Piaggi
WKWilliam C. Knowler
William C. Knowler
JKJonathan Krakoff
Jonathan Krakoff
DCDouglas C. Chang
Douglas C. Chang
We compared the ability of 1- and 2-h plasma glucose concentrations (1h-PG and 2h-PG, respectively), derived from a 75-g oral glucose tolerance test (OGTT), to predict retinopathy. 1h-PG and 2h-PG concentrations, measured in a longitudinal study of an American Indian community in the southwestern U.S., a population at high risk for type 2 diabetes, were analyzed to assess the usefulness of the 1h-PG to identify risk of diabetic retinopathy (DR). Cross-sectional (n = 2,895) and longitudinal (n = 1,703) cohorts were assessed for the prevalence and incidence of DR, respectively, in relation to deciles of 1h-PG and 2h-PG concentrations. Areas under the receiver operating characteristic (ROC) curves for 1h-PG and 2h-PG were compared with regard to predicting DR, as assessed by direct ophthalmoscopy. Prevalence and incidence of DR, based on direct ophthalmoscopy, changed in a similar manner across the distributions of 1h-PG and 2h-PG concentrations. ROC analysis showed that 1h-PG and 2h-PG were of similar value in identifying prevalent and incident DR using direct ophthalmoscopy. 1h-PG cut points of 230 and 173 mg/dL were comparable to 2h-PG cut points of 200 mg/dL (type 2 diabetes) and 140 mg/dL (impaired glucose tolerance), respectively. 1h-PG is a useful predictor of retinopathy risk, has a predictive value similar to that of 2h-PG, and may be considered as an alternative glucose time point during an OGTT.

25 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DCDouglas C. Chang
Douglas C. Chang
Paolo PiaggiPaolo Piaggi
Paolo Piaggi
RHRobert L. Hanson
Robert L. Hanson
WKWilliam C. Knowler
William C. Knowler
JBJohn Bucci
John Bucci
JKJonathan Krakoff
Jonathan Krakoff
New biomarkers for type 2 diabetes mellitus (T2DM) may aid diagnosis, drug development or clinical treatment. Evidence is increasing for the adaptive immune system’s role in T2DM and suggests the presence of unidentified autoantibodies. While high-density protein microarrays have emerged as a useful technology to identify possible novel autoantigens in autoimmune diseases, its application in T2DM has lagged. In Pima Indians, the HLA haplotype (HLA-DRB1*02) is protective against T2DM and, when studied when they have normal glucose tolerance, subjects with this HLA haplotype have higher insulin secretion compared to those without the protective haplotype. Possible autoantibody biomarkers were identified using microarrays containing 9480 proteins in plasma from Pima Indians with T2DM without the protective haplotype (n = 7) compared with those with normal glucose regulation (NGR) with the protective haplotype (n = 11). A subsequent validation phase involving 45 cases and 45 controls, matched by age, sex and specimen storage time, evaluated 77 proteins. Eleven autoantigens had higher antibody signals among T2DM subjects with the lower insulin-secretion HLA background compared with NGR subjects with the higher insulin-secretion HLA background (p<0.05, adjusted for multiple comparisons). PPARG2 and UBE2M had lowest p-values (adjusted p = 0.023) while PPARG2 and RGS17 had highest case-to-control antibody signal ratios (1.7). A multi-protein classifier involving the 11 autoantigens had sensitivity, specificity, and area under the receiver operating characteristics curve of 0.73, 0.80, and 0.83 (95% CI 0.74–0.91, p = 3.4x10-8), respectively. This study identified 11 novel autoantigens which were associated with T2DM and an HLA background associated with reduced insulin secretion. While further studies are needed to distinguish whether these antibodies are associated with insulin secretion via the HLA background, T2DM more broadly, or a combination of the two, this study may aid the search for autoantibody biomarkers by narrowing the list of protein targets.

21 July 2017 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
DCDouglas C. Chang
Douglas C. Chang
Paolo PiaggiPaolo Piaggi
Paolo Piaggi
RHRobert L. Hanson
Robert L. Hanson
WKWilliam C. Knowler
William C. Knowler
CBClifton Bogardus
Clifton Bogardus
JKJonathan Krakoff
Jonathan Krakoff